MicroVision interim CFO acquires 9,395 company shares

MicroVision, Inc. Interim CFO Stephen Hrynewich acquired 9,395 shares of common stock in a direct transaction with the company.

Rhea-AI Filing Summary

MicroVision, Inc. Interim CFO Stephen Hrynewich acquired 9,395 shares of common stock in a direct transaction with the company. The shares were purchased at $0.5322 per share, matching the closing price on March 13, 2026, under a Subscription Agreement executed on March 15, 2026.

After this acquisition, Hrynewich directly holds 172,092 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions for reporting and short-swing profit purposes.

Insights

Insider transactions analyst

Interim CFO makes a modest, exempt share purchase from MicroVision.

The Interim CFO, Stephen Hrynewich, acquired 9,395 shares of MicroVision common stock directly from the company at $0.5322 per share, equal to the market closing price on March 13, 2026, via a Subscription Agreement.

The Form 4 treats this as a grant/award-type acquisition, and the company states it is intended to be exempt under Rule 16b-3. Following the transaction, Hrynewich directly holds 172,092 shares, so the new purchase represents a relatively small addition to his overall reported position.

The filing shows no derivative positions and no sales, suggesting this is a straightforward, compensation-related or alignment-oriented purchase from the issuer rather than an open-market trade. On its own, this looks like a routine insider transaction without a thesis-changing impact.

Insider Trade Summary

Grant/Award: 9,395 shares

Grant/Award 1 txn

Insider Hrynewich Stephen

Role Interim CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,395	$0.5322	$5K

Holdings After Transaction: Common Stock — 172,092 shares (Direct)

Footnotes (2)

1. F1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 9,395 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.
2. F2. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MicroVision (MVIS) Interim CFO Stephen Hrynewich report on this Form 4?

Interim CFO Stephen Hrynewich reported acquiring 9,395 shares of MicroVision common stock. He obtained the shares directly from the company at a price of $0.5322 per share under a Subscription Agreement dated March 15, 2026.

At what price did the MicroVision Interim CFO acquire his new MVIS shares?

He acquired the 9,395 shares at $0.5322 per share. The footnote states this price matched the closing price of MicroVision’s common stock on March 13, 2026, and the shares were purchased directly from the company, not on the open market.

How many MicroVision (MVIS) shares does the Interim CFO hold after this transaction?

After the reported acquisition, Interim CFO Stephen Hrynewich directly holds 172,092 shares of MicroVision common stock. This total includes the 9,395 newly acquired shares described in the Form 4 and reflects his direct ownership position following the transaction.

Was the MicroVision Interim CFO’s share acquisition treated as an exempt insider transaction?

Yes. A footnote explains that the purchase is intended to be an exempt transaction under Rule 16b-3. That rule can exempt certain insider transactions, such as issuer-directed purchases or awards, from short-swing profit recovery requirements under Section 16 of the Exchange Act.

How did the MicroVision Interim CFO acquire the new MVIS shares, open market or directly from the company?

He acquired the shares directly from MicroVision pursuant to a Subscription Agreement executed on March 15, 2026. The filing specifies that the 9,395 shares of common stock were purchased from the company at $0.5322 per share, rather than via open-market trading.

Does this MicroVision Form 4 show any stock sales or derivative exercises by the Interim CFO?

No. The Form 4 shows a single acquisition of 9,395 common shares coded as a grant or award-type transaction. There are no reported stock sales, option exercises, or other derivative transactions, and the derivative holdings section is empty in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 09:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hrynewich Stephen

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/15/2026		A(2)		9,395	A	$0.5322	172,092	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 9,395 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.

2. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

	/s/ Drew G. Markham, attorney-in-fact for Stephen Hrynewich	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.